Similar Items
-
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials
by: Feuer C, et al.
Published: (2009-10-01) -
P15-24. Good participatory practice guidelines begin to take root
by: Feuer C, et al.
Published: (2009-10-01) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
by: Moodie Z, et al.
Published: (2009-10-01) -
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
by: Allan C deCamp, et al.
Published: (2017-01-01) -
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
by: Magagula D, et al.
Published: (2009-10-01)